Today news
About the same in other media
Yes, DeepMind crunches the numbers – but is it really a magic bullet?
Reading now: 908
The most interesting development of the week had nothing to do with Facebook or even Google losing its appeal against a €2.4bn fine from the European commission for abusing its monopoly of search to the detriment of competitors to its shopping service.
The bigger deal was that DeepMind, a London-based offshoot of Google (or, to be precise, its holding company, Alphabet) was moving into the pharmaceutical business via a new company called Isomorphic Labs, the goal of which is grandly described as
. Read more on theguardian.comAbout this in other media
Binance resumes DOGE withdrawals days after Elon Musk’s comments cointelegraph.com /2 years ago
Why Elon Musk Wrote "Exactly" On Twitter And What It Means For Crypto Investors ndtv.com /2 years ago
Football industry embraces crypto as Messi helps 'fan tokens' take off economictimes.indiatimes.com /2 years ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
